Autophagy in clear cell ovarian cancer, a potential marker for hypoxia and poor prognosis?

Journal of Pathology

Volumn 228, Issue 4, 2012, Pages 434-436

  Gibson, Spencer B ^a,b,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CANCERCARE MANITOBA   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Atg complex; Autophagy; Cancer; Ovary; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; AUTOPHAGY PROTEIN 5; BECLIN 1; BEVACIZUMAB; CHLOROQUINE; COLCHICINE; MICROTUBULE ASSOCIATED PROTEIN 1; MICROTUBULE ASSOCIATED PROTEIN 1 LIGHT CHAIN 3; PLATINUM; PROTEIN BNIP3; UNCLASSIFIED DRUG; LIGHT CHAIN 3, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; BIOLOGICAL MARKER; HYDROXYCHLOROQUINE;

APOPTOSIS; AUTOPHAGOSOME; AUTOPHAGY; CANCER CELL; CANCER PROGNOSIS; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CELL SURVIVAL; CLEAR CELL CARCINOMA; GLIOBLASTOMA; HUMAN; HYPOXIA; IMMUNOHISTOCHEMISTRY; METABOLIC STRESS; NONHUMAN; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REVIEW; ADENOCARCINOMA; FEMALE; METABOLISM; OVARY TUMOR; PHYSIOLOGY; CANCER RESISTANCE; CELL HYPOXIA; DRUG POTENTIATION; ELECTRON MICROSCOPY; HYPOXIC CELL; MYOPATHY; UPREGULATION;

ADENOCARCINOMA, CLEAR CELL; AUTOPHAGY; FEMALE; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; OVARIAN NEOPLASMS;

EID: 84871210596     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4100     Document Type: Review

References (14)

1. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000; 290: 1717-1721.
2. Glick D, Barth S, Macleod KF. Autophagy: Cellular and molecular mechanisms. J Pathol 2010; 221: 3-12.
3. Lee HS, Daniels BH, Salas E, et al. Clinical utility of LC3 and p62 immunohistochemistry in diagnosis of drug-induced autophagic vacuolar myopathies: A case-control study. PLoS One 2012; 7: E36221.
4. Rosenfeldt M, Nixon C, Liu E, et al. Analysis of macroautophagy by immunohistochemistry. Autophagy 2012; 8: 963-969.
5. Azad MB, Chen Y, Henson ES, et al. Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3. Autophagy 2008; 4: 195-204.
6. Hu YL, Jahangiri A, De Lay M, et al. Hypoxia-induced tumor cell autophagy mediates resistance to anti-angiogenic therapy. Autophagy 2012; 8: 979-981.
7. Vaupel P. The role of hypoxia-induced factors in tumor progression. Oncologist 2004; 9 (Suppl 5): 10-17.
8. Zhang J, Ney PA. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ 2009; 16: 939-946.
9. Zhang J, Ney PA. Mechanisms and biology of B-cell leukemia/ lymphoma 2/adenovirus E1B interacting protein 3 and Nip-like protein X. Antioxid Redox Signal 2011; 14: 1959-1969.
10. Burton TR, Gibson SB. The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death. Cell Death Differ 2009; 16: 515-523.
11. Hu YL, DeLay M, Jahangiri A, et al. Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma. Cancer Res 2012; 72: 1773-1783.
12. Kobel M, Kalloger SE, Boyd N, et al. Ovarian carcinoma subtypes are different diseases: Implications for biomarker studies. PLoS Med 2008; 5: E232.
13. Sugiyama T, Kamura T, Kigawa J, et al. Clinical characteristics of clear cell carcinoma of the ovary: A distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 2000; 88: 2584-2589.
14. Spowart, JE, Townsend KN, Huwait H, et al. The autophagy protein LC3A correlates with hypoxia and is a prognostic marker of patient survival in clear cell ovarian cancer. J Pathol 2012; 228: 436-446.